XGN Exagen: Net earnings per share for the last four quarters

Public company logo of Exagen Inc (XGN)

Exagen Inc. (XGN) generates revenue through the development of diagnostic systems for identifying autoimmune pathologies, where early-stage lupus testing plays a pivotal role. Business growth is supported by the integration of neural networks into the AVISE platform to accurately predict disease progression. The asset's market value, which this chart shows as 18.80, is complemented by a streamlined mechanism for the rapid transport of biomaterials to central hubs.

Exagen Inc (XGN): Net earnings per share for the last 12 months from 02/11/2024 to 11/18/2026

exagen.com - analytical breakdowns and key metrics (XGN)

- market price and analyst price targets:
Fundamental company valuation:XGN, Exagen Diagnostics
Mass-produced product of Exagen Inc.

This indicator measures the rate of change in earnings per share over a rolling annual window, providing a real-time assessment of operational efficiency. Growth in EPS YoY TTM demonstrates the business's ability to generate income above inflation and withstand the pressure of Fed rates on margins. For Exagen Inc. (XGN), this metric reflects the monetization of the AVISE platform and the integration of AI algorithms into lupus diagnostics. By analyzing the current EPS YoY TTM momentum, investors can evaluate the productivity of the company's innovation pipeline.

Competitor analysis

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)